Aptevo Therapeutics Files Definitive Proxy Statement
Ticker: APVO · Form: DEF 14A · Filed: Apr 25, 2025 · CIK: 1671584
| Field | Detail |
|---|---|
| Company | Aptevo Therapeutics Inc. (APVO) |
| Form Type | DEF 14A |
| Filed Date | Apr 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, regulatory-filing, shareholder-meeting
Related Tickers: APVO
TL;DR
APVO filed its proxy statement, shareholders meeting soon.
AI Summary
Aptevo Therapeutics Inc. filed a Definitive Proxy Statement (DEF 14A) on April 25, 2025, for a special meeting of stockholders. The filing concerns the company's proxy materials, with no fee required for this filing. The company is headquartered in Seattle, Washington.
Why It Matters
This filing is a standard regulatory requirement for public companies to inform shareholders about upcoming meetings and related proposals, impacting corporate governance and shareholder voting.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEF 14A) and does not contain new financial or operational information that would inherently increase risk.
Key Players & Entities
- Aptevo Therapeutics Inc. (company) — Registrant
- 20250425 (date) — Filing Date
- 20250514 (date) — Period of Report
- Seattle, Washington (location) — Company Headquarters
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or Definitive Proxy Statement, is used by companies to solicit proxies from shareholders for an upcoming meeting, providing detailed information about the matters to be voted upon.
When was this DEF 14A filed by Aptevo Therapeutics Inc.?
Aptevo Therapeutics Inc. filed this DEF 14A on April 25, 2025.
What is the period of report for this filing?
The conformed period of report for this filing is May 14, 2025.
Is there a fee required for this filing?
No fee was required for this filing, as indicated by the checkmark next to 'No fee required'.
Where is Aptevo Therapeutics Inc. located?
Aptevo Therapeutics Inc. is located at 2401 4th Avenue, Suite 1050, Seattle, Washington 98121.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 25, 2025 regarding Aptevo Therapeutics Inc. (APVO).